If you feel you may be a suitable candidate for The Registry of Advanced Diabetic Retinopathy please ask your ophthalmologist for more details, or phone/mail our office.
Ophthalmologists are asked to refer participants that they feel fit the suitability criteria by posting, faxing or e-mailing a completed referral and consent form, or by completing an online referral form via this website or via the RADAR App. Following this, the participant will be contacted by The Registry of Advanced Diabetic Retinopathy, and a DNA collection kit will be posted to them along with instructions.
The participant will be asked to attend their local doctor or pathology service for blood collection, and return the DNA (usually blood) sample to the registry using a pre-paid package.
Analysis of the sample will occur once it is received by the registry, with DNA and RNA extraction and serum analysis conducted in an accredited genetic testing facility. The results will then be analysed by the Chief Investigator, Professor Jamie Craig.
This service is offered at no cost to the participant. Their current diabetic retinopathy treatment regime will not be affected, as they will continue to visit their regular ophthalmologist. Participation is completely voluntary and can be withdrawn at any time.
It is envisaged that genes associated with vision loss from diabetes may be discovered as a result of collecting and analysing the DNA specimens. This will help in the discovery of new and better treatments for diabetic retinopathy in future.